1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market
2.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Component, 2023 (US$ Million)
2.3. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method, 2023 (US$ Million)
2.4. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Process, 2023 (US$ Million)
2.5. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By End-User, 2023 (US$ Million)
2.6. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Competitive Analysis
3.1. Market Positioning of Key Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
3.2. Strategies Adopted by Cell And Gene Therapy Manufacturing Quality Control (QC) Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cell And Gene Therapy Manufacturing Quality Control (QC) Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Equipment & Accessories
5.3.2. Consumables
5.3.3. Others

6. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Sterility Testing
6.3.2. Purity Testing
6.3.3. Potency Testing
6.3.4. Identity Testing
6.3.5. Others (stability, viability, etc.)

7. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Upstream Processes
7.3.2. Downstream Processes
7.3.3. Process Development

8. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Pharmaceutical & Biotechnology Companies
8.3.2. Contract Manufacturing Organizations


9. North America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
9.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
9.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
9.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
9.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

10. UK and European Union Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
10.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
10.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
10.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

11. Asia Pacific Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.4.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.4.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.4.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.5.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.5.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.5.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
11.6.1.6.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
11.6.1.6.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
11.6.1.6.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

12. Latin America Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
12.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
12.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
12.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

13. Middle East and Africa Cell And Gene Therapy Manufacturing Quality Control (QC) Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.5. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13.6.Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Region, 2022-2032, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.6.1.1.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.6.1.1.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.6.1.1.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.6.1.2.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.6.1.2.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.6.1.2.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Component, 2022-2032, USD (Million)
13.6.1.3.2. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Analytical Method, 2022-2032, USD (Million)
13.6.1.3.3. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By Process, 2022-2032, USD (Million)
13.6.1.3.4. Cell And Gene Therapy Manufacturing Quality Control (QC) Market: By End-User, 2022-2032, USD (Million)

14. Company Profile
14.1. Lonza Group
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Charles River Laboratories
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Eurofins Scientific
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. WuXiAppTec
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. bioMerieux SA
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Bio-Rad Laboratories, Inc.
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Bio-Techne Corporation
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. QIAGEN
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Merck KGaA
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Intertek Group plc
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Thermo Fisher Scientific, Inc.
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. F. Hoffmann-La Roche Ltd.
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Other Notable Players
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives